checkAd

     125  0 Kommentare ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder - Seite 2

    The approval of ProAir Digihaler is based on the review of a supplemental new drug application (sNDA) submitted by Teva to the FDA. ProAir Digihaler combines a breath-activated, multi-dose dry powder inhaler with albuterol, the most widely used asthma rescue medication, with a built-in electronic module and a companion mobile app.

    “One of the challenges physicians are faced with in caring for their asthma and COPD patients is knowing if their patients are using their inhaled medication as they should. That’s what makes a product like this so important to doctor-patient discussions,” said Tushar Shah, M.D., Senior Vice President, Global Specialty Clinical Development at Teva Pharmaceuticals. “Offering a tool that enables doctors to see data on their patients’ inhaler usage will allow them to have more productive conversations about identifying issues and how to manage their illness.”

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Teva Pharmaceutical Industries Ltd ADR!
    Long
    15,05€
    Basispreis
    1,70
    Ask
    × 7,88
    Hebel
    Short
    19,07€
    Basispreis
    2,16
    Ask
    × 7,86
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    ProAir Digihaler will be available in 2019 through a small number of “Early Experience” Programs, which will be conducted in partnership with healthcare systems and in limited geographies, in order to gather real-world experience. A national launch is planned for 2020. For more information, visit www.ProAirDigihaler.com.

    APPROVED USES

    ProAir Digihaler (albuterol sulfate) Inhalation Powder is a prescription medicine used in people 4 years of age and older to:

    • treat or prevent bronchospasm in people who have reversible obstructive airway disease
    • prevent exercise-induced bronchospasm

    ProAir Digihaler contains a built-in electronic module that detects, records and stores inhaler event information. ProAir Digihaler may be used with, and transmits information to, a mobile app. ProAir Digihaler does not need to be connected to the mobile app in order for you to take your medicine.

    IMPORTANT SAFETY INFORMATION

    • Do not use ProAir Digihaler (albuterol sulfate) Inhalation Powder if you are allergic to albuterol sulfate, lactose, milk proteins, or any of the ingredients in ProAir Digihaler. Ask your healthcare provider if you have any questions or are not sure
    • Before using ProAir Digihaler, tell your healthcare provider about all of your medical conditions, including if you:
      • have heart problems
      • have high blood pressure (hypertension)
      • have convulsions (seizures)
      • have thyroid problems
      • have diabetes
      • have low potassium levels in your blood
      • are pregnant or planning to become pregnant
      • are breastfeeding or planning to breastfeed
    • Tell your healthcare provider about all the medicines you take, especially:
      • other inhaled medicines or asthma medicines
      • beta blocker medicines
      • diuretics
      • digoxin
      • monoamine oxidase inhibitors
      • tricyclic antidepressants
    • Do not increase your dose or take extra doses of ProAir Digihaler without first talking to your healthcare provider
    • Get medical help right away if ProAir Digihaler no longer helps your symptoms, your symptoms get worse or you need to use your inhaler more often
    • While you are using ProAir Digihaler, do not use other inhaled rescue medicines and asthma medicines unless your healthcare provider tells you to do so
    • ProAir Digihaler may cause serious side effects, including:
      • worsening trouble breathing, coughing and wheezing (paradoxical bronchospasm). If this happens, stop using ProAir Digihaler and call your healthcare provider or get emergency help right away. This is more likely to happen with your first use of a new asthma inhalation medicine
      • heart problems, including faster heart rate and higher blood pressure
      • possible death in people with asthma who use too much ProAir Digihaler
      • allergic reactions. Call your healthcare provider right away if you have the following symptoms of an allergic reaction:
        • itchy skin
        • swelling beneath your skin or in your throat
        • rash
        • worsening trouble breathing
      • changes in laboratory blood values (sugar, potassium)
    • The most common side effects of ProAir Digihaler include:
      • back pain
      • body aches and pain
      • upset stomach
      • sinus headache
      • urinary tract infection
      • your heart feels like it is pounding or racing (palpitations)
      • chest pain
      • fast heart rate
      • shakiness
      • nervousness
      • headache
      • dizziness
      • sore throat
      • runny nose
    • These are not all of the possible side effects of ProAir Digihaler. For more information, ask your healthcare provider or pharmacist
    • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

    Please read the full Prescribing Information.

    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder - Seite 2 Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder, the first and only digital …

    Schreibe Deinen Kommentar

    Disclaimer